Pharmaceutical compositions for induction of apoptosis of cancer cells and inhibition of reverse transcriptase of human immunodeficiency virus-1
Disclosed is the use of gold (III) complexes of porphyrins, Schiff-bases, bis(pyridyl)carboxamides and bis(pyridyl)sulfonamides as anti-tumor and anti-HIV agents.
Patent Number: TWI338692B
Application Number: TW2003125500A
Inventor: CHE CHIMING
Priority Date: 16 Sep 2002
Priority Number: TWI338692B
Application Date: 16 Sep 2003
Publication Date: 11 Mar 2011
IPC Current: C07D048722 | A61K0031555 | A61K00317072 | A61P003118 | A61P003500
Assignee Applicant: The University of Hong Kong
Title: Pharmaceutical compositions for induction of apoptosis of cancer cells and inhibition of reverse transcriptase of human immunodeficiency virus-1
Usefulness: Pharmaceutical compositions for induction of apoptosis of cancer cells and inhibition of reverse transcriptase of human immunodeficiency virus-1
Summary: (A) is useful to induce apoptosis of cancer cells and also to inhibit human immunodeficiency virus-1 reverse transcriptase (claimed).
Novelty: Use of gold (III) complex to induce apoptosis of cancer cells and to inhibit human immunodeficiency virus-1 reverse transcriptase
生物醫學
醫藥成分
香港
